Mundipharma pays Allos $50 million up front for ex-US rights to lymphoma drug
11 May 2011
Nancy Faigen
Please Login to read the full article.
11 May 2011
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Allos buy could be silver lining for Spectrum after cancer drug setback
- Takeda claims Aurora A kinase inhibitor lead as it takes alisertib into Phase III
- Allos' Folotyn falls at EU regulator: casts doubt over future US sales
- SymBio's bendamustine moves forward in first-line setting in Japan
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
